Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $7.12 billion. The enterprise value is $9.10 billion.
| Market Cap | 7.12B |
| Enterprise Value | 9.10B |
Important Dates
The last earnings date was Wednesday, July 24, 2024, before market open.
| Earnings Date | Jul 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 105.76 million shares outstanding. The number of shares has decreased by -3.07% in one year.
| Shares Outstanding | 105.76M |
| Shares Change (YoY) | -3.07% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 2.82% |
| Owned by Institutions (%) | 100.90% |
| Float | 102.65M |
Valuation Ratios
The trailing PE ratio is 10.00 and the forward PE ratio is 8.27. TMHC's PEG ratio is 1.51.
| PE Ratio | 10.00 |
| Forward PE | 8.27 |
| PS Ratio | 0.96 |
| Forward PS | 0.92 |
| PB Ratio | 1.29 |
| P/FCF Ratio | n/a |
| PEG Ratio | 1.51 |
Enterprise Valuation
| EV / Earnings | 12.41 |
| EV / Sales | 1.23 |
| EV / EBITDA | 9.04 |
| EV / EBIT | 9.42 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.22 |
| Debt / FCF | n/a |
| Interest Coverage | -427.54 |
Financial Efficiency
Return on equity (ROE) is 13.70% and return on invested capital (ROIC) is 9.33%.
| Return on Equity (ROE) | 13.70% |
| Return on Assets (ROA) | 8.30% |
| Return on Capital (ROIC) | 9.33% |
| Revenue Per Employee | $2.64M |
| Profits Per Employee | $261,788 |
| Employee Count | 2,800 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 0.97 |
Taxes
In the past 12 months, TMHC has paid $235.07 million in taxes.
| Income Tax | 235.07M |
| Effective Tax Rate | 24.28% |
Stock Price Statistics
The stock price has increased by +41.01% in the last 52 weeks. The beta is 1.95, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +41.01% |
| 50-Day Moving Average | 58.23 |
| 200-Day Moving Average | 53.38 |
| Relative Strength Index (RSI) | 76.58 |
| Average Volume (20 Days) | 876,355 |
Short Selling Information
The latest short interest is 2.49 million, so 2.35% of the outstanding shares have been sold short.
| Short Interest | 2.49M |
| Short Previous Month | 2.68M |
| Short % of Shares Out | 2.35% |
| Short % of Float | 2.43% |
| Short Ratio (days to cover) | 2.60 |
Income Statement
In the last 12 months, TMHC had revenue of $7.39 billion and earned $733.01 million in profits. Earnings per share was $6.73.
| Revenue | 7.39B |
| Gross Profit | 1.77B |
| Operating Income | 955.61M |
| Pretax Income | 968.08M |
| Net Income | 733.01M |
| EBITDA | 1.01B |
| EBIT | 965.82M |
| Earnings Per Share (EPS) | $6.73 |
Balance Sheet
The company has $248.77 million in cash and $2.23 billion in debt, giving a net cash position of -$1.98 billion or -$18.75 per share.
| Cash & Cash Equivalents | 248.77M |
| Total Debt | 2.23B |
| Net Cash | -1.98B |
| Net Cash Per Share | -$18.75 |
| Equity (Book Value) | 5.53B |
| Book Value Per Share | 52.25 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$165.00 million and capital expenditures -$29.82 million, giving a free cash flow of -$194.82 million.
| Operating Cash Flow | -165.00M |
| Capital Expenditures | -29.82M |
| Free Cash Flow | -194.82M |
| FCF Per Share | -$1.84 |
Margins
Gross margin is 24.00%, with operating and profit margins of 12.94% and 9.92%.
| Gross Margin | 24.00% |
| Operating Margin | 12.94% |
| Pretax Margin | 13.11% |
| Profit Margin | 9.92% |
| EBITDA Margin | 13.62% |
| EBIT Margin | 13.08% |
| FCF Margin | -2.64% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.07% |
| Shareholder Yield | 3.07% |
| Earnings Yield | 10.30% |
| FCF Yield | -2.74% |
Analyst Forecast
The average price target for TMHC is $66.50, which is -1.17% lower than the current price. The consensus rating is "Buy".
| Price Target | $66.50 |
| Price Target Difference | -1.17% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |